Discovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries

Molecular and Cellular Proteomics

Volumn 10, Issue 12, 2011, Pages

  Guergova Kuras, Mariana ^a   Kurucz, István ^b   Hempel, William ^a   Tardieu, Nadège ^a   Kádas, János ^b   Malderez Bloes, Carole ^a   Jullien, Anne ^a   Kieffer, Yann ^a   Hincapie, Marina ^c   Guttman, András ^c   Csánky, Eszter ^d,e   Dezso, Balázs ^f   Karger, Barry L ^c   Takács, László ^a,b  

^a Biosystems International   (France)

^b Biosystems International Kft   (Hungary)

^c NORTHEASTERN UNIVERSITY   (United States)

^d UNIVERSITY OF DEBRECEN   (Hungary)

^e Semmelweis Hospital   (Hungary)

^f UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA2 GLYCOPROTEIN; ANTIGEN; COMPLEMENT COMPONENT C9; COMPLEMENT FACTOR H; CYTOKERATIN 19 FRAGMENT; EPITOPE; HAPTOGLOBIN; MONOCLONAL ANTIBODY; COMPLEMENT FACTOR H, HUMAN; GLYCOPROTEIN; LRG1 PROTEIN, HUMAN; PROTEOME; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CANCER STAGING; CARCINOMA IN SITU; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MOLECULAR LIBRARY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PROCESSING; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING; ADOLESCENT; ADULT; AGED; ANIMAL; ANTIBODY SPECIFICITY; AREA UNDER THE CURVE; BAGG ALBINO MOUSE; BLOOD; CASE CONTROL STUDY; CHEMISTRY; EARLY DIAGNOSIS; IMMUNOLOGY; LUNG TUMOR; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PROTEOMICS; RECEIVER OPERATING CHARACTERISTIC;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA 1-ANTICHYMOTRYPSIN; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; AREA UNDER CURVE; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; COMPLEMENT FACTOR H; EARLY DETECTION OF CANCER; FEMALE; GLYCOPROTEINS; HAPTOGLOBINS; HUMANS; IMMUNOASSAY; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; PROTEOME; PROTEOMICS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 83055168546     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.010298     Document Type: Article

References (56)

1. Stewart, B. W., and Kleihues, P. (Eds): World Cancer Report. IARCPress. Lyon 2003, 181-188
2. Henschke, C. I., Yankelevitz, D. F., Libby, D. M., Pasmantier, M. W., Smith, J. P., and Miettinen, O. S. (2006) Survival of patients with stage I lung cancer detected on CT screening. N. Engl. J. Med. 355, 1763-1771 (Pubitemid 44631359)
3. van Klaveren, R. J., Oudkerk, M., Prokop, M., Scholten, E. T., Nackaerts, K., Vernhout, R., van Iersel, C. A., van den Bergh, K. A., van 't Westeinde, S., van der Aalst, C., Thunnissen, E., Xu, D. M., Wang, Y., Zhao, Y., Gietema, H. A., de Hoop, B. J., Groen, H. J., de Bock, G. H., van Ooijen, P., Weenink, C., Verschakelen, J., Lammers, J. W., Timens, W., Willebrand, D., Vink, A., Mali, W., and de Koning, H. J. (2009) Management of lung nodules detected by volume CT scanning. N. Engl. J. Med. 361, 2221-2229
4. Aberle, D. R., Adams, A. M., Berg, C. D., Black, W. C., Clapp, J. D., Fagerstrom, R. M., Gareen, I. F., Gatsonis, C., Marcus, P. M., and Sicks, J. D. (2011) Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N. Engl. J. Med. 365, 395-409
5. Kulpa, J., Wójcik, E., Reinfuss, M., and Kołodziejski, L. (2002) Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients. Clin. Chem. 48, 1931-1937 (Pubitemid 35222751)
6. Ebert, W., Hoppe, M., Muley, T., and Drings, P. (1997) Monitoring of therapy in inoperable lung cancer patients by measurement of CYFRA 21-1, TPA-TP CEA, and NSE. Anticancer Res. 17, 2875-2878 (Pubitemid 27434809)
7. Beane, J., Spira, A., and Lenburg, M. E. (2009) Clinical impact of high-throughput gene expression studies in lung cancer. J. Thorac. Oncol. 4, 109-118
8. Ocak, S., Chaurand, P., and Massion, P. P. (2009) Mass spectrometry-based proteomic profiling of lung cancer. Proc. Am. Thorac. Soc. 6, 159-170
9. Zhong, L., Coe, S. P., Stromberg, A. J., Khattar, N. H., Jett, J. R., and Hirschowitz, E. A. (2006) Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J. Thorac. Oncol. 1, 513-519 (Pubitemid 47181397)
10. Brower, V. (2009) Biomarker studies abound for early detection of lung cancer. J. Natl. Cancer Inst. 101, 11-13
11. Rifai, N., Gillette, M. A., and Carr, S. A. (2006) Protein biomarker discovery and validation: The long and uncertain path to clinical utility. Nat. Biotechnol. 24, 971-983 (Pubitemid 44215392)
12. Uhlén, M., Björling, E., Agaton, C., Szigyarto, C. A., Amini, B., Andersen, E., Andersson, A. C., Angelidou, P., Asplund, A., Asplund, C., Berglund, L., Bergström, K., Brumer, H., Cerjan, D., Ekström, M., Elobeid, A., Eriksson, C., Fagerberg, L., Falk, R., Fall, J., Forsberg, M., Björklund, M. G., Gumbel, K., Halimi, A., Hallin, I., Hamsten, C., Hansson, M., Hedhammar, M., Hercules, G., Kampf, C., Larsson, K., Lindskog, M., Lodewyckx, W., Lund, J., Lundeberg, J., Magnusson, K., Malm, E., Nilsson, P., Odling, J., Oksvold, P., Olsson, I., Oster, E., Ottosson, J., Paavilainen, L., Persson, A., Rimini, R., Rockberg, J., Runeson, M., Sivertsson, A., Sköllermo, A., Steen, J., Stenvall, M., Sterky, F., Strömberg, S., Sundberg, M., Tegel, H., Tourle, S., Wahlund, E., Waldén, A., Wan, J., Wernérus, H., Westberg, J., Wester, K., Wrethagen, U., Xu, L. L., Hober, S., and Pontén, F. (2005) A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol. Cell Proteomics 4, 1920-1932
13. Blow, N. (2007) Antibodies: The generation game. Nature 447, 741-744
14. Hoagland, L. F., 4th, Campa, M. J., Gottlin, E. B., Herndon, J. E., 2nd, and Patz, E. F., Jr. (2007) Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer. Cancer 110, 2260-2268 (Pubitemid 350100749)
15. Okano, T., Kondo, T., Kakisaka, T., Fujii, K., Yamada, M., Kato, H., Nishimura, T., Gemma, A., Kudoh, S., and Hirohashi, S. (2006) Plasma proteomics of lung cancer by a linkage of multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis. Proteomics 6, 3938-3948 (Pubitemid 44065171)
16. Higashiyama, M., Doi, O., Yokouchi, H., Kodama, K., Nakamori, S., and Tateishi, R. (1995) Alpha-1-antichymotrypsin expression in lung adenocarcinoma and its possible association with tumor progression. Cancer 76, 1368-1376
17. Ajona, D., Castaño, Z., Garayoa, M., Zudaire, E., Pajares, M. J., Martinez, A., Cuttitta, F., Montuenga, L. M., and Pio, R. (2004) Expression of complement factor H by lung cancer cells: Effects on the activation of the alternative pathway of complement. Cancer Res. 64, 6310-6318 (Pubitemid 39129436)
18. Pujol, J. L., Grenier, J., Daurès, J. P., Daver, A., Pujol, H., and Michel, F. B. (1993) Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res. 53, 61-66 (Pubitemid 23019377)
19. The World Health Organization (1982) Histological typing of lung tumours. Neoplasma 29, 111-123
20. Kullolli, M., Hancock, W. S., and Hincapie, M. (2008) Preparation of a high-performance multi-lectin affinity chromatography (HP-M-LAC) adsorbent for the analysis of human plasma glycoproteins. J. Sep. Sci. 31, 2733-2739
21. Takacs, L., Guttman, A., and Kuras, M. (2007) Normalization of complex analyte mixtures, Published Patent Application, PCT/IB2006/003161
22. Pontecorvo, G. (1975) Production of mammalian somatic cell hybrids by means of polyethylene glycol treatment. Somatic Cell Genet. 1, 397-400
23. Zhang, J. H., Chung, T. D., and Oldenburg, K. R. (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen 4, 67-73 (Pubitemid 29278954)
24. Weivoda, S., Andersen, J. D., Skogen, A., Schlievert, P. M., Fontana, D., Schacker, T., Tuite, P., Dubinsky, J. M., and Jemmerson, R. (2008) ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand. J. Immunol. Methods 336, 22-29
25. Gogolak, P., Rethi, B., Szatmari, I., Lanyi, A., Dezso, B., Nagy, L., and Rajnavolgyi, E. (2007) Differentiation of CD1a- and CD1a+ monocytederived dendritic cells is biased by lipid environment and PPARgamma. Blood 109, 643-652 (Pubitemid 46105965)
26. Tsakiris, I., Soos, G., Nemes, Z., Kiss, S. S., Andras, C., Szantó, J., and Dezso, B. (2008) The presence of carboxypeptidase-M in tumour cells signifies epidermal growth factor receptor expression in lung adenocarcinomas: the coexistence predicts a poor prognosis regardless of EGFR levels. J. Cancer Res. Clin. Oncol. 134, 439-451 (Pubitemid 351322380)
27. Csanky, E., Olivova, P., Rajnavolgyi, E., Hempel, W., Tardieu, N., Katalin, E. T., Jullien, A., Malderez-Bloes, C., Kuras, M., Duval, M. X., Nagy, L., Scholtz, B., Hancock, W., Karger, B., Guttman, A., and Takacs, L. (2007) Monoclonal antibody proteomics: Discovery and prevalidation of chronic obstructive pulmonary disease biomarkers in a single step. Electrophoresis 28, 4401-4406 (Pubitemid 350259042)
28. Peracaula, R., Barrabés, S., Sarrats, A., Rudd, P. M., and de Llorens, R. (2008) Altered glycosylation in tumours focused to cancer diagnosis. Dis. Markers 25, 207-218
29. Kingsmore, S. F. (2006) Multiplexed protein measurement: Technologies and applications of protein and antibody arrays. Nat. Rev. Drug Discov. 5, 310-320
30. Wang, D., Hincapie, M., Guergova-Kuras, M., Kadas, J., Takacs, L., and Karger, B. L. (2010) Antigen identification and characterization of lung cancer specific monoclonal antibodies produced by mAb proteomics. J. Proteome Res. 9, 1834-1842
31. Abdullah, M., Schultz, H., Kähler, D., Branscheid, D., Dalhoff, K., Zabel, P., Vollmer, E., and Goldmann, T. (2009) Expression of the acute phase protein haptoglobin in human lung cancer and tumor-free lung tissues. Pathol. Res. Pract. 205, 639-647
32. Molina, R., Filella, X., Augé, J. M., Fuentes, R., Bover, I., Rifa, J., Moreno, V., Canals, E., Viñolas, N., Marquez, A., Barreiro, E., Borras, J., and Viladiu, P. (2003) Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis: Comparison with the main clinical and pathological prognostic factors. Tumour Biol 24, 209-218 (Pubitemid 37500571)
33. Ostroff, R. M., Bigbee, W. L., Franklin, W., Gold, L., Mehan, M., Miller, Y. E., Pass, H. I., Rom, W. N., Siegfried, J. M., Stewart, A., Walker, J. J., Weissfeld, J. L., Williams, S., Zichi, D., and Brody, E. N. (2010) Unlocking biomarker discovery: Large scale application of aptamer proteomic technology for early detection of lung cancer. PLoS One 5, e15003
34. Gabay, C., and Kushner, I. (1999) Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340, 448-454 (Pubitemid 29084777)
35. Shirai, R., Hirano, F., Ohkura, N., Ikeda, K., and Inoue, S. (2009) Upregulation of the expression of leucine-rich alpha(2)-glycoprotein in hepatocytes by the mediators of acute-phase response. Biochem. Biophys. Res. Commun. 382, 776-779
36. Okuyama, N., Ide, Y., Nakano, M., Nakagawa, T., Yamanaka, K., Moriwaki, K., Murata, K., Ohigashi, H., Yokoyama, S., Eguchi, H., Ishikawa, O., Ito, T., Kato, M., Kasahara, A., Kawano, S., Gu, J., Taniguchi, N., and Miyoshi, E. (2006) Fucosylated haptoglobin is a novel marker for pancreatic cancer: A detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int. J. Cancer 118, 2803-2808 (Pubitemid 43673360)
37. Yoon, S. J., Park, S. Y., Pang, P. C., Gallagher, J., Gottesman, J. E., Dell, A., Kim, J. H., and Hakomori, S. I. (2010) N-Glycosylation status of beta-haptoglobin in sera of patients with prostate cancer vs. benign prostate diseases. Int. J. Oncol. 36, 193-203
38. Bharti, A., Ma, P. C., Maulik, G., Singh, R., Khan, E., Skarin, A. T., and Salgia, R. (2004) Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer. Anticancer Res. 24, 1031-1038 (Pubitemid 38624933)
39. Cheng, Z. Z., Corey, M. J., Pärepalo, M., Majno, S., Hellwage, J., Zipfel, P. F., Kinders, R. J., Raitanen, M., Meri, S., and Jokiranta, T. S. (2005) Complement factor H as a marker for detection of bladder cancer. Clin. Chem. 51, 856-863 (Pubitemid 40577922)
40. Junnikkala, S., Hakulinen, J., Jarva, H., Manuelian, T., Bjørge, L., Bützow, R., Zipfel, P. F., and Meri, S. (2002) Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells. Br. J. Cancer 87, 1119-1127 (Pubitemid 35418107)
41. Amornsiripanitch, N., Hong, S., Campa, M. J., Frank, M. M., Gottlin, E. B., and Patz, E. F., Jr. (2010) Complement factor H autoantibodies are associated with early stage NSCLC. Clin. Cancer Res. 16, 3226-3231
42. Yu, K. H., Rustgi, A. K., and Blair, I. A. (2005) Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. J. Proteome Res. 4, 1742-1751 (Pubitemid 41464802)
43. Koomen, J. M., Shih, L. N., Coombes, K. R., Li, D., Xiao, L. C., Fidler, I. J., Abbruzzese, J. L., and Kobayashi, R. (2005) Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins. Clin. Cancer Res. 11, 1110-1118 (Pubitemid 40175760)
44. Chen, Y., Lim, B. K., and Hashim, O. H. (2009) Different altered stage correlative expression of high abundance acute-phase proteins in sera of patients with epithelial ovarian carcinoma. J. Hematol. Oncol. 2, 37-43
45. Andersen, J. D., Boylan, K. L., Jemmerson, R., Geller, M. A., Misemer, B., Harrington, K. M., Weivoda, S., Witthuhn, B. A., Argenta, P., Vogel, R. I., and Skubitz, A. P. (2010) Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients. J. Ovarian Res. 3, 21-34
46. Heo, S. H., Lee, S. J., Ryoo, H. M., Park, J. Y., and Cho, J. Y. (2007) Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS. Proteomics 7, 4292-4302
47. Gao, W. M., Kuick, R., Orchekowski, R. P., Misek, D. E., Qiu, J., Greenberg, A. K., Rom, W. N., Brenner, D. E., Omenn, G. S., Haab, B. B., and Hanash, S. M. (2005) Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. BMC Cancer 5, 110-119
48. Siemes, C., Visser, L. E., Coebergh, J. W., Splinter, T. A., Witteman, J. C., Uitterlinden, A. G., Hofman, A., Pols, H. A., and Stricker, B. H. (2006) C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J. Clin. Oncol. 24, 5216-5222 (Pubitemid 46631365)
49. Trichopoulos, D., Psaltopoulou, T., Orfanos, P., Trichopoulou, A., and Boffetta, P. (2006) Plasma C-reactive protein and risk of cancer: A prospective study from Greece. Cancer Epidemiol. Biomarkers Prev. 15, 381-384 (Pubitemid 43348407)
50. Proctor, M. J., Morrison, D. S., Talwar, D., Balmer, S. M., O'Reilly, D. S., Foulis, A. K., Horgan, P. G., and McMillan, D. C. (2011) An inflammationbased prognostic score (mGPS) predicts cancer survival independent of tumour site: A Glasgow Inflammation Outcome Study. Br. J. Cancer 104, 726-734
51. Proctor, M. J., Talwar, D., Balmar, S. M., O'Reilly, D. S., Foulis, A. K., Horgan, P. G., Morrison, D. S., and McMillan, D. C. (2010) The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters: Initial results of the Glasgow Inflammation Outcome Study. Br. J. Cancer 103, 870-876
52. Kiri, V. A., Fabbri, L. M., Davis, K. J., and Soriano, J. B. (2009) Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking. Respir. Med. 103, 85-90
53. Engels, E. A., Wu, X., Gu, J., Dong, Q., Liu, J., and Spitz, M. R. (2007) Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Res. 67, 6520-6527 (Pubitemid 47037538)
54. Chen, C. B., Su, Y. C., Huang, T. T., Ho, H. C., Chang, Y. T., Tung, Y. T., and Lee, W. C. (2008) Differentially expressed serum haptoglobin alpha chain isoforms with potential application for diagnosis of head and neck cancer. Clin. Chim. Acta 398, 48-52
55. Wieskopf, B., Demangeat, C., Purohit, A., Stenger, R., Gries, P., Kreisman, H., and Quoix, E. (1995) Cyfra 21-1 as a biologic marker of non-small cell lung cancer: Evaluation of sensitivity, specificity, and prognostic role. Chest 108, 163-169
56. Dohmoto, K., Hojo, S., Fujita, J., Yang, Y., Ueda, Y., Bandoh, S., Yamaji, Y., Ohtsuki, Y., Dobashi, N., Ishida, T., and Takahara, J. (2001) The role of caspase 3 in producing cytokeratin 19 fragment (CYFRA21-1) in human lung cancer cell lines. Int. J. Cancer 91, 468-473 (Pubitemid 32115099)